Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122374) titled 'Effectiveness and safety of recombinant mussel mucin combined with medical dressings for post-mesotherapy skin repair in a clinical trial' on April 13.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: West China Hospital, Sichuan University
Condition:
Damage to skin barrier after aesthetic medicine treatment
Intervention:
Test side:After mesotherapy treatment, the test product was applied to one side of the face according to a randomization table.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-13
Target Sample Size: Test side:35;Control side:...